32282-06-7

Basic information

• Product Name: N-Ethyl-2,3-Pyridinediamine
• Synonyms: N-Ethyl-2,3-Pyridinediamine;2,3-Pyridinediamine, N2-ethyl-
• CAS NO: 32282-06-7
• Molecular Formula: C₇H₁₁N₃
• Molecular Weight: 137.18234
• Product Categories: pharmacetical
• Mol File: 32282-06-7.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 303.181 °C at 760 mmHg
• Flash Point: 137.159 °C
• Appearance: /
• Density: 1.135 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.626
• CAS DataBase Reference: N-Ethyl-2,3-Pyridinediamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Ethyl-2,3-Pyridinediamine(32282-06-7)
• EPA Substance Registry System: N-Ethyl-2,3-Pyridinediamine(32282-06-7)

Safety Data

• Hazardous Substances Data: 32282-06-7(Hazardous Substances Data)

Usage

Description

N-Ethyl-2,3-Pyridinediamine, a chemical compound with the molecular formula C7H10N2, is a derivative of pyridine and belongs to the group of amines. It is a clear, colorless to yellow liquid with a strong odor and is considered hazardous if not handled or used properly due to its potential to cause skin and eye irritation.

Uses

Used in Pharmaceutical Industry:
N-Ethyl-2,3-Pyridinediamine is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and enhance their properties.
Used in Dye Industry:
N-Ethyl-2,3-Pyridinediamine is used as an intermediate in the synthesis of dyes, contributing to the creation of a wide range of colorants for various applications.
Used in Organic Compounds Synthesis:
N-Ethyl-2,3-Pyridinediamine is used as an intermediate in the synthesis of other organic compounds, playing a crucial role in the production of various chemical products.
Used in Water Treatment Chemicals Industry:
N-Ethyl-2,3-Pyridinediamine is used as a corrosion inhibitor in the manufacturing of water treatment chemicals, helping to prevent the deterioration of materials in contact with water and ensuring the longevity and efficiency of water systems.

InChI:InChI=1/C7H11N3/c1-2-9-7-6(8)4-3-5-10-7/h3-5H,2,8H2,1H3,(H,9,10)

Upstream product

• 26820-65-5 ethyl-(3-nitropyridin-2-yl)amine 
• 99314-93-9 N²-acetyl-N³-benzyloxycarbonyl-2,3-diaminopyridine 
• 99314-92-8 N²-amino-N³-benzyloxycarbonylaminopyridine 
• 452-58-4 2,3-Diaminopyridine 
• 5470-18-8 2-Chloro-3-nitropyridine 
• 99314-99-5 2-acetylamino-3-aminopyridine 

Downstream Products

• 1399050-23-7 N₂-ethyl-N₃-phenylpyridine-2,3-diamine 
• 448211-19-6 1-ethyl-1H-imidazo[4,5-b]pyridin-2(3H)-one 
• 1399050-24-8 3-chloro-3-ethyl-1-phenyl-2,3-dihydro-1H-imidazo[4,5-b]pyridine-3-ium-2-ide 
• 380378-90-5 [2-chloro-N-{2-(ethylamino)-3-pyridinyl}-5-bromo-3-] pyridinecarboxamide 
• 78686-86-9 5-bromo-2-chloro-pyridine-3-carbonyl chloride 
• 1028254-47-8 2-(2-Amino-phenylethynyl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one 
• 1026854-16-9 5-Ethyl-10-methyl-2-o-tolylethynyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one 
• 1026873-42-6 2-[(E)-2-(4-Amino-phenyl)-vinyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one 
• 189393-20-2 5,11-Dihydro-11-ethyl-5-methyl-8-phenylethynyl-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one 

Relevant articles and documents

SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted benzimidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

PYRIDYL CARBENE PHOSPHORESCENT EMITTERS

Organometallic compounds comprising an imidazole carbene ligand having a N-containing ring fused to the imidazole ring are provided. In particular, the N-containing ring fused to the imidazole ring may contain one nitrogen atom or more than one nitrogen a

HETEROCYCLYC SULFONAMIDES HAVING EDG-I ANTAGONISTIC ACTIVITY

The invention relates to chemical compounds of formula (I), (Ia) and (Ib) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal, such as man.